A siRNA mediated hepatic dpp4 knockdown affects lipid, but not glucose metabolism in diabetic mice.
Systemic inhibition of dipeptidyl peptidase 4 (dpp4) represents an effective and established treatment option for type 2 diabetes (T2D). The current study investigated in mice if a liver selective knock-down of dpp4 by therapeutic siRNAs could be a novel, similarly effective treatment option for T2D...
Main Authors: | Sven Wolfgang Görgens, Kerstin Jahn-Hofmann, Dinesh Bangari, Sheila Cummings, Christiane Metz-Weidmann, Uwe Schwahn, Paulus Wohlfart, Matthias Schäfer, Maximilian Bielohuby |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0225835 |
Similar Items
-
Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice
by: Nicole Ziegler, et al.
Published: (2020-08-01) -
Control of (pre)-analytical aspects in immunoassay measurements of metabolic hormones in rodents
by: Maximilian Bielohuby, et al.
Published: (2018-04-01) -
Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies
by: Britta Schneider, et al.
Published: (2012-01-01) -
siRNA knockdown of Tau kinases in primary neurons
by: Genfors, Björn
Published: (2012) -
Nanolayered siRNA Dressing for Sustained Localized Knockdown
by: Wang, Mary, et al.
Published: (2014)